Acorda Therapeutics Inc Foglalás / Részvény
Mi az Acorda Therapeutics Inc Foglalás / Részvény?
A Foglalás / Részvény az Acorda Therapeutics Inc - -8.21
Mi a Foglalás / Részvény meghatározása?
Az egy részvényre jutó könyv szerinti érték egy vállalat eszköze, mínusz kötelezettségek, osztva a fennálló részvények számával.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Foglalás / Részvény a Health Care szektor a NASDAQ-on cégekben a Acorda Therapeutics Inc -hoz képest
Mit csinál Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
foglalás / részvény -hoz hasonló cégek Acorda Therapeutics Inc
- Opto Circuits (India) nak Foglalás / Részvény -8.45 van
- California Resources Corp nak Foglalás / Részvény -8.41 van
- MBIA nak Foglalás / Részvény -8.37 van
- Dynavision nak Foglalás / Részvény -8.27 van
- Vivint Smart Home Inc nak Foglalás / Részvény -8.24 van
- Rusoro Mining nak Foglalás / Részvény -8.22 van
- Acorda Therapeutics Inc nak Foglalás / Részvény -8.21 van
- Town Sports International nak Foglalás / Részvény -8.11 van
- MDC Partners nak Foglalás / Részvény -8.06 van
- Ansal Properties & Infrastructure nak Foglalás / Részvény -8.05 van
- Lanesborough Real Estate Investment Trust nak Foglalás / Részvény -8.04 van
- Mechel PJSC nak Foglalás / Részvény -7.79 van
- Setco Automotive nak Foglalás / Részvény -7.77 van